Investors

Investors

Related Content

Model Medicines BIO 2026 presentation on MDL-001 antiviral and MDL-4102 BRD4 programs advancing toward regulatory filings

Events

Jun 22, 2026

Model Medicines to Present Data on Two First-in-Class Programs Ahead of Catalyst Regulatory Filings at the 2026 BIO International Convention in San Diego

Model Medicines presentation on end-to-end AI drug discovery at Fierce Biotech Week 2026

Events

May 14, 2026

Model Medicines to Present End-to-End AI Drug Discovery Platform at Fierce Biotech Week 2026 in Boston